ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Emergency Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,384Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 82

$536K Total Retail Price of All Prescriptions

Rank: 2 out of 82

68 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 68 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

32% of this provider’s 68 patients filled at least one prescription for a schedule three drug, compared to an average of 26%.

Risky Drugs to Seniors

3% of this provider’s 5,214 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 13%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

123 is the average number of prescriptions (including refills) per patient, compared to an average of 4.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LEVOTHYROXINE SODIUM 256 173 1 3
FUROSEMIDE 251 163 2 4
WARFARIN SODIUM 246 142 3 19
LISINOPRIL 237 118 4 5
NAMENDA 236 196 5 24
POTASSIUM CHLORIDE 211 122 6 13
DIVALPROEX SODIUM 187 119 7 30
SIMVASTATIN 183 102 8 6
PHENYTOIN SODIUM EXTENDED 153 67 9 38
AMLODIPINE BESYLATE 139 110 10 10
CYMBALTA 139 89 10 46
POLYETHYLENE GLYCOL 3350 135 65 12 61
LACTULOSE 128 66 13 65
GLIPIZIDE 125 68 14 68
GEODON 119 78 15 70
PANTOPRAZOLE SODIUM 118 111 16 51
CRESTOR 116 79 17 21
GABAPENTIN 113 63 18 11
ZIPRASIDONE HCL 112 75 19 73
DONEPEZIL HCL 105 105 20 45
HYDROCODONE-ACETAMINOPHEN 100 71 S3 21 1
MIRTAZAPINE 97 84 22 54
CLOZAPINE 95 58 23 81
QUETIAPINE FUMARATE 95 46 23 56
NOVOLIN R 89 53 25 83
EXELON 87 64 26 84
FAMOTIDINE 85 35 27 39
NEXIUM 83 73 28 18
TRAZODONE HCL 81 24 29 52
IBUPROFEN 78 50 30 24
PREDNISONE 74 47 31 14
OLANZAPINE 73 59 32 90
THEOPHYLLINE ANHYDROUS 72 58 33 91
OMEPRAZOLE 67 40 34 9
NITROGLYCERIN PATCH 64 53 35 72
BACLOFEN 63 14 36 99
LAMOTRIGINE 63 31 36 99
TAMSULOSIN HCL 63 32 36 66
METOPROLOL TARTRATE 60 36 39 12
AMITRIPTYLINE HCL 59 29 R 40 34
HALOPERIDOL 59 30 40 105
CARBIDOPA-LEVODOPA 58 44 42 108
RANITIDINE HCL 58 14 42 23
IPRATROPIUM-ALBUTEROL 58 43 42 108
CLOPIDOGREL 58 47 42 29
RISPERIDONE 56 50 46 47
ABILIFY 55 41 47 112
CLONIDINE HCL 54 27 48 115
METFORMIN HCL 54 18 48 16
BENZTROPINE MESYLATE 53 25 R 50 117
FLUOXETINE HCL 53 42 50 117
ADVAIR DISKUS 52 32 52 74
LYRICA 52 32 52 119
DILANTIN 51 22 54 57
TRAMADOL HCL 51 48 54 7
CYCLOBENZAPRINE HCL 50 18 R 56 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.